Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ORMD-0801
ORMD-0801
Oramed’s oral insulin flunks phase 3 diabetes test, sending stock down 70%
Fierce Biotech
Thu, 01/12/23 - 10:39 am
Oramed
diabetes
type 2 diabetes
clinical trials
insulin
oral insulin
ORMD-0801
Oramed phase 2 insulin drug data ‘paint an exciting picture’ in rocky NASH landscape
Fierce Biotech
Tue, 09/13/22 - 07:56 pm
Oramed
NASH
diabetes
Pfizer
insulin
clinical trials
ORMD-0801
Novo Nordisk Vs. Oramed - A Second Look At The Battle For Oral Insulin
Seeking Alpha
Mon, 08/22/16 - 10:10 pm
Novo Nordisk
Oramed
insulin
oral insulin
diabetes
NN1953
ORMD-0801
Oramed Can Benefit As MannKind Opens The Diabetes Market For Novel Drugs
Seeking Alpha
Tue, 04/8/14 - 11:48 am
Oramed
MannKind
diabetes
ORMD-0801
The Dream Of The Insulin Pill: Oramed Vs. Rivals
Seeking Alpha
Thu, 02/6/14 - 07:47 am
insulin
diabetes
Oramed
oral insulin
ORMD-0801
NN1954
Novo Nordisk
Oramed's Oral Insulin Pill Data 'Completely Worthless'
TheStreet.com
Mon, 02/3/14 - 09:41 am
Oramed Pharmaceuticals
oral insulin
diabetes
ORMD-0801
Oramed's Data Will Define A New Standard For Diabetes
Seeking Alpha
Tue, 01/28/14 - 11:52 am
diabetes
Oramed Pharmaceuticals
ORMD-0801
oral insulin
MannKind's Afrezza And The Oramed Threat
Seeking Alpha
Thu, 05/23/13 - 10:29 am
MannKind
Afrezza
diabetes
Oramed Pharmaceuticals
ORMD-0801
Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin
PharmaLive
Sat, 02/16/13 - 12:16 pm
Oramed Pharmaceuticals
oral insulin
type 1 diabetes
type 2 diabetes
ORMD-0801
ORMD-0901